Health TrialsbyHealthPanel

Caprini Score in Venous Surgery: a Prospective Cohort Study

ConditionsVenous ThromboembolismVaricose Veins
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPirogov Russian National Research Medical University

About this trial

The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age over 18 years

any kind of varicose vein surgery

follow up for 4 weeks after the procedure

examination for VTE at 2-4 weeks after the procedure, including duplex ultrasound

Disqualifiers

None

Trial population

Any patient with varicose veins that undergoing any kind of varicose vein surgery.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • EVLT

    Procedure/Surgery

    Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type

  • RFA

    Procedure/Surgery

    Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique

  • USFS

    Procedure/Surgery

    Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration

  • HL/stripping

    Procedure/Surgery

    High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein

  • Miniphlebectomy

    Procedure/Surgery

    Miniphlebectomy of any varicose veins under local, regional or general anaesthesia

  • Sclerotherapy

    Procedure/Surgery

    Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration

  • GCS

    Device

    Graduated compression stockings may be used after procedure by the decision of the doctor

  • LMWH

    Drug

    Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

any episode of VTE

symptomatic or asymptomatic, confirmed by instrumental diagnostics

Time frame
0-4 weeks after procedure

Secondary outcomes

1

symptomatic deep vein thrombosis

symptomatic deep vein thrombosis confirmed by duplex ultrasound

Time frame
0-4 weeks after procedure
2

symptomatic pulmonary embolism

symptomatic pulmonary embolism confirmed by perfusion isotope scanning or CT pulmonary angiography

Time frame
0-4 weeks after procedure
3

asymtomatic deep vein thrombosis

asymptomatic DVT revealed by duplex ultrasound

Time frame
2-4 weeks after procedure
4

endovenous thermal-induced thrombosis

EHIT revealed by duplex ultrasound

Time frame
0-4 weeks after procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Pirogov Russian National Research Medical University

Lead sponsor

Source ClinicalTrials.gov
Apply now